Skip to Content

TEVA 5290 (Voriconazole 200 mg)

Pill imprint TEVA 5290 has been identified as Voriconazole 200 mg.

Voriconazole is used in the treatment of aspergillosis, invasive; cutaneous fungal infection; fungal infection, internal and disseminated; coccidioidomycosis, meningitis; candidemia (and more), and belongs to the drug class azole antifungals. There is positive evidence of human fetal risk during pregnancy. Voriconazole 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Voriconazole 200 mg TEVA 5290
Voriconazole 200 mg TEVA 5290
Voriconazole 200 mg TEVA 5290
TEVA 5290
200 mg
Elliptical / Oval
Prescription only
Drug Class:
Azole antifungals
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC):
Inactive Ingredients:
croscarmellose sodium
lactose monohydrate
magnesium stearate
polyethylene glycol
polyvinyl alcohol
corn starch
magnesium silicate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
42291-0900 AvKare, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.